PNC Financial Services Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.8K | Buy |
7,597
+6,191
| +440% | +$50.4K | ﹤0.01% | 2993 |
|
|
2025
Q1 | $11K | Buy |
1,406
+511
| +57% | +$4.01K | ﹤0.01% | 3793 |
|
|
2024
Q4 | $13.3K | Sell |
895
-970
| -52% | -$14.4K | ﹤0.01% | 3695 |
|
|
2024
Q3 | $28.5K | Sell |
1,865
-852
| -31% | -$13K | ﹤0.01% | 3345 |
|
|
2024
Q2 | $41.4K | Buy |
2,717
+740
| +37% | +$11.3K | ﹤0.01% | 3124 |
|
|
2024
Q1 | $37.3K | Buy |
1,977
+470
| +31% | +$8.87K | ﹤0.01% | 3123 |
|
|
2023
Q4 | $28.8K | Sell |
1,507
-2,394
| -61% | -$45.7K | ﹤0.01% | 3242 |
|
|
2023
Q3 | $70K | Buy |
3,901
+422
| +12% | +$7.58K | ﹤0.01% | 2774 |
|
|
2023
Q2 | $70.7K | Buy |
3,479
+1,521
| +78% | +$30.9K | ﹤0.01% | 2842 |
|
|
2023
Q1 | $35.7K | Sell |
1,958
-873
| -31% | -$15.9K | ﹤0.01% | 3166 |
|
|
2022
Q4 | $58.5K | Buy |
2,831
+279
| +11% | +$5.77K | ﹤0.01% | 2885 |
|
|
2022
Q3 | $67K | Buy |
2,552
+888
| +53% | +$23.3K | ﹤0.01% | 2790 |
|
|
2022
Q2 | $42K | Buy |
+1,664
| New | +$42K | ﹤0.01% | 3103 |
|